RhumbLine Advisers’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.92M | Buy |
|
|||||
|
2025
Q1 | $1.05M | Buy |
|
|||||
|
2024
Q4 | $1.55M | Sell |
|
|||||
|
2024
Q3 | $2.48M | Buy |
|
|||||
|
2024
Q2 | $2.08M | Buy |
|
|||||
|
2024
Q1 | $4.01M | Sell |
|
|||||
|
2023
Q4 | $6.82M | Buy |
|
|||||
|
2023
Q3 | $5.01M | Buy |
|
|||||
|
2023
Q2 | $6.74M | Buy |
|
|||||
|
2023
Q1 | $6.05M | Buy |
|
|||||
|
2022
Q4 | $3.69M | Buy |
|
|||||
|
2022
Q3 | $2.72M | Buy |
|
|||||
|
2022
Q2 | $3.83M | Buy |
|
|||||
|
2022
Q1 | $5.41M | Sell |
|
|||||
|
2021
Q4 | $11.7M | Buy |
|
|||||
|
2021
Q3 | $11.1M | Sell |
|
|||||
|
2021
Q2 | $15M | Buy |
|
|||||
|
2021
Q1 | $10.4M | Sell |
|
|||||
|
2020
Q4 | $8.3M | Sell |
|
|||||
|
2020
Q3 | $7.35M | Sell |
|
|||||
|
2020
Q2 | $5.38M | Buy |
|